Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK HAAS

Allopathic & Osteopathic Physicians Pathology Anatomic Pathology & Clinical Pathology

NPI
1750330478
CMS profile
1238518
Location
LOS ANGELES, CA

General Payments · PY2018–2024

$105,259.87

  • Reported across 58 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$49,520.89

24 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $46,855.00 9
Travel and Lodging $2,063.92 8
Food and Beverage $601.97 7

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $10,609.51 3
PY2019 $17,761.33 4
PY2020 $9,436.64 11
PY2021 $115.50 1
PY2022 $6,000.00 2
PY2023 $11,816.00 13
PY2024 $49,520.89 24

Payment records · PY2024 (24)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ARGENX US, INC. $237.50 10/09/2024 Consulting Fee Undisputed 01/23/2026 1142112873 CMS
ARGENX US, INC. $237.50 10/16/2024 Consulting Fee Undisputed 01/23/2026 1142112847 CMS
ARGENX US, INC. $2,137.50 12/17/2024 Consulting Fee Undisputed 01/23/2026 1142121127 CMS
AstraZeneca UK Limited $10,800.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 1094018587 CMS
AstraZeneca UK Limited $8,550.00 07/10/2024 Consulting Fee Undisputed 01/23/2026 1093951156 CMS
AstraZeneca UK Limited $8,325.00 10/16/2024 Consulting Fee Undisputed 01/23/2026 1093940894 CMS
Novartis Pharmaceuticals Corporation $571.63 02/08/2024 Travel and Lodging Undisputed 01/23/2026 1086954911 CMS
Novartis Pharmaceuticals Corporation $140.00 02/08/2024 Food and Beverage Undisputed 01/23/2026 1086954921 CMS
Novartis Pharmaceuticals Corporation $7,600.00 02/09/2024 Consulting Fee Undisputed 01/23/2026 1086954923 CMS
Novartis Pharmaceuticals Corporation $209.97 02/09/2024 Food and Beverage Undisputed 01/23/2026 1086954925 CMS
Novartis Pharmaceuticals Corporation $431.52 02/09/2024 Travel and Lodging Undisputed 01/23/2026 1086954927 CMS
Novartis Pharmaceuticals Corporation $214.60 02/09/2024 Travel and Lodging Undisputed 01/23/2026 1086954929 CMS
Novartis Pharmaceuticals Corporation $70.00 02/09/2024 Travel and Lodging Undisputed 01/23/2026 1086954931 CMS
Novartis Pharmaceuticals Corporation $36.22 04/22/2024 Food and Beverage Undisputed 01/23/2026 1086954913 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $361.56 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1118837011 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $306.71 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1118837013 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $68.25 10/05/2024 Food and Beverage Undisputed 01/23/2026 1118837015 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $33.41 10/05/2024 Food and Beverage Undisputed 01/23/2026 1118837017 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $69.74 10/05/2024 Food and Beverage Undisputed 01/23/2026 1118837019 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $7,467.50 11/05/2024 Consulting Fee Undisputed 01/23/2026 1118837021 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $52.99 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1118837023 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $54.91 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1118837025 CMS
Travere Therapeutics, Inc. $1,500.00 04/30/2024 Consulting Fee Undisputed 01/23/2026 1149919934 CMS
Travere Therapeutics, Inc. $44.38 10/23/2024 Food and Beverage Undisputed 01/23/2026 1149919930 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.